For example, a recent clinical trial showed that IFN-β treatment within 24 h, once developed a defined cold/flu, significantly enhanced morning peak expiratory flow recovery, reduced the need for additional treatment, and boosted innate immunity in difficult-to-treat asthma patients50. The gene discussed is IFNB1; the disease is asthma.